
Biomatter
We build impossible enzymes for your visionary products.
Vilnius · Founded 2018 · $6.5M raised
- Headquarters
- Vilnius
- Founded
- 2018
- Business Model
- B2B
- Website
- biomatter.ai
- Total Funding
- $6.5M
- Last Round
- $6.5M SeedAug 2024
- Rounds
- 1
About
Biomatter is a synthetic biology company based in Vilnius, Lithuania, that builds exceptional enzymes for health and sustainable manufacturing applications. Its proprietary Intelligent Architecture™ platform enables near-perfect control over protein design, allowing creation of previously impossible enzymes and enzyme-based products. Biomatter partners with leading global companies on projects ranging from stand-alone enzyme products to multi-enzyme chemical manufacturing solutions, supporting clients from initial concept and design through experimental validation, scale-up, and protein production.
Summary
Biomatter is a Biotech company based in Vilnius, founded in 2018. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Aug 2024.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2024
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company